Fraunhofer USA Ctr-Molecular is categorized under Commercial Biotechnical Research in Newark, DE and active since 2001.
Fraunhofer USA Ctr-Molecular was established in 2001, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Vidadi Yusibov, Executive Director at the company’s single location by writing to 9 Innovation Way, Newark, Delaware DE 19711 or by phoning (302) 369-1708. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Fraunhofer USA Ctr-Molecular |
| Contact Person: | Vidadi Yusibov, Executive Director |
| Address: | 9 Innovation Way, Newark, Delaware 19711 |
| Phone Number: | (302) 369-1708 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417110 |
| Share This Business: |
Fraunhofer USA Ctr-Molecular was started in 2001 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Vidadi Yusibov, Executive Director for inquiries that concern Fraunhofer USA Ctr-Molecular by calling the company number (302) 369-1708, as your correspondence is most welcome. Additionally, the physical location of the single location of Fraunhofer USA Ctr-Molecular can be found at the coordinates 39.67744,-75.73301 as well as the street address 9 Innovation Way in Newark, Delaware 19711.
For its online presence, you may visit Fraunhofer USA Ctr-Molecular’s website at and engage with its social media outlets through on Twitter and on Facebook.